Is it time to stop searching for MRSA? Environmental hygiene is an important part of control. by Dance, D, Cunningham, R, Gaunt, P, Stewart, V, Swales, J

Subcutaneous adipose tissue insulin resistance and lipolysis in patients with nonalcoholic steatohepatitis by Armstrong, M, Hazlehurst, J, Hull, D, Borrows, S, Guo, K, Yu, J, Barton, D, Gaunt, P, Gough, S, Tomlinson, J, Newsome, P

Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial by Armstrong, M, Barton, D, Gaunt, P, Hull, D, Guo, K, Stocken, D, Gough, S, Tomlinson, J, Brown, R, Hübscher, S, Newsome, P

Glucagon like peptide 1 analogue, Liraglutide, reduces adipose insulin resistance and hepatic de novo lipogenesis in Nonalcoholic Steatohepatitis: Sub-study results of a phase II r... by Armstrong, M, Hull, D, Guo, K, Barton, D, Hazlehurst, J, Nasiri, M, Gathercole, L, Yu, J, Gaunt, P, Gough, S, Tomlinson, J, Newsome, P

Revised guidelines for control of MRSA in hospitals: finding the most useful point. by Rahman, M, Sanderson, P, Bentley, A, Barrett, S, Karim, Q, Teare, E, Chaudhuri, A, Alcock, SR, Corcoran, G, Azadian, B, Dance, D, Gaunt, P, Cunningham, R, Ahmad, F, Garvey, R, Hayek, L, Chattopadhyay, B, Wiggins, R, Sheppard, M, Barkham, T, Wright, E, Rimmer, D, Moulsdale, M, Falkiner, F

Clinicians' views of patient-initiated follow-up in head and neck cancer: a qualitative study to inform the PETNECK2 Trial by Lorenc, A, Wells, M, Fulton-Lieuw, T, Nankivell, P, Mehanna, H, Jepson, M, Karwath, A, Main, B, Firth, C, Gaunt, C, Greaves, C, Moore, D, Watson, E, Gkoutos, G, Ozakinci, G, Wolstenholme, J, Dretzke, J, Brett, J, Duda, J, Matheson, L, Cherrill, L-R, Calvert, M, Kiely, P, Gaunt, P, Chernbumroong, S, Mittal, S, Thomas, S, Winter, S, Wong, W